Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Medicinal Chemistry
|
September 5, 2024
Development of Tailless Homologue Receptor (TLX) Agonist Chemical Tools
Emily C Hank, Minh Sai, Till Kasch, et al.
Journal of Medicinal Chemistry
|
September 18, 2025
Development of Potent and Selective Dual PPARδ/sEH Modulators from an AI-Designed Scaffold
Xiu Ge, Till Kasch, Max Lewandowski, et al.
Journal of Medicinal Chemistry
|
July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer Preference
Felix Nawa, Arthur Kardanov, Till Kasch, et al.
Communications Chemistry
|
July 1, 2024
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing
Minh Sai, Emily C Hank, Hin-Man Tai, et al.
Journal of Medicinal Chemistry
|
November 24, 2025
Structural Tuning of Partial RXR Agonism and Antagonism
Max Lewandowski, Marie Granger-Rivière, Domenic Mayer, et al.
Journal of Medicinal Chemistry
|
June 3, 2026
An Activator of Tailless' Repressor Function Stimulates Anti-Neurodegenerative Gene Expression
Emily C Hank, Romy Busch, Úrsula López-García, et al.
Journal of Medicinal Chemistry
|
January 18, 2024
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties
Max Lewandowski, Melania Carmina, Loris Knümann, et al.
Journal of Medicinal Chemistry
|
December 8, 2023
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency
Gustave Adouvi, Felix Nawa, Marco Ballarotto, et al.
Journal of Medicinal Chemistry
|
July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism
Sabine Willems, Romy Busch, Felix Nawa, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Medicinal Chemistry
|
September 5, 2024
Development of Tailless Homologue Receptor (TLX) Agonist Chemical Tools
Emily C Hank, Minh Sai, Till Kasch, et al.
Journal of Medicinal Chemistry
|
September 18, 2025
Development of Potent and Selective Dual PPARδ/sEH Modulators from an AI-Designed Scaffold
Xiu Ge, Till Kasch, Max Lewandowski, et al.
Journal of Medicinal Chemistry
|
July 24, 2025
Development of an RXR Agonist Scaffold with Pronounced Homodimer Preference
Felix Nawa, Arthur Kardanov, Till Kasch, et al.
Communications Chemistry
|
July 1, 2024
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing
Minh Sai, Emily C Hank, Hin-Man Tai, et al.
Journal of Medicinal Chemistry
|
November 24, 2025
Structural Tuning of Partial RXR Agonism and Antagonism
Max Lewandowski, Marie Granger-Rivière, Domenic Mayer, et al.
Journal of Medicinal Chemistry
|
June 3, 2026
An Activator of Tailless' Repressor Function Stimulates Anti-Neurodegenerative Gene Expression
Emily C Hank, Romy Busch, Úrsula López-García, et al.
Journal of Medicinal Chemistry
|
January 18, 2024
Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties
Max Lewandowski, Melania Carmina, Loris Knümann, et al.
Journal of Medicinal Chemistry
|
December 8, 2023
Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency
Gustave Adouvi, Felix Nawa, Marco Ballarotto, et al.
Journal of Medicinal Chemistry
|
July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 Agonism
Sabine Willems, Romy Busch, Felix Nawa, et al.
Page
of 1